A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing
REDUCE
1 other identifier
interventional
452
1 country
1
Brief Summary
In this study, the investigators will evaluate the effect of a health system initiative aiming to change clinician opioid prescribing behaviors using two behavioral economic interventions - individual audit feedback and peer comparison feedback of clinicians.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2019
CompletedFirst Posted
Study publicly available on registry
January 31, 2019
CompletedStudy Start
First participant enrolled
September 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2020
CompletedMarch 6, 2020
March 1, 2020
6 months
January 17, 2019
March 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the mean number of pills per opioid prescription
The primary outcome is the change in the mean number of pills prescribed per opioid prescription from baseline to the intervention period.
Six months
Secondary Outcomes (1)
Change in proportion of patient visits with an opioid prescription
Six months
Other Outcomes (3)
Change in morphine milligram equivalents per opioid prescription
Six months
Change in mean number of opioid pills per patient-visit
Six months
Change in proportion of patient-visits with non-opioid pain prescription
Six months
Study Arms (4)
Control
NO INTERVENTIONNo intervention
Individual Audit
EXPERIMENTALClinicians will receive individual audit feedback informing them of their performance.
Peer Comparison
EXPERIMENTALClinicians will receive peer comparison feedback informing them of how their performance compares to their peers.
Individual Audit and Peer Comparison
EXPERIMENTALClinicians will receive individual audit feedback informing them of their performance and peer comparison feedback informing them of how their performance compares to their peers.
Interventions
Practice sites randomly assigned to have individual audit feedback will be sent information by email to each clinician at the site each month for the duration of the intervention period. The email will inform the clinician that the health system is doing monthly audits and provide them the number of patients in the last month for whom they prescribed 30 opioid pills per prescription or higher.
Practice sites randomly assigned to have peer comparison feedback will be sent information by email to each clinician at the site each month for the duration of the intervention period. Data on the mean number of opioid pills per prescription and the proportion of visits with an opioid prescription will be delivered using a 3-month rolling average as follows: a) If clinician is above median: informed how their data compares to the median; b) If clinician is below median but above 10th percentile: informed how their data compares to the 10th percentile; c) If clinician is 10th percentile or below: informed of their data and commended for being a "low prescriber."
Eligibility Criteria
You may qualify if:
- Clinicians
- \. Practiced primarily at participating emergency department or urgent care center
- Patients
- Presented to a participating emergency department or urgent care center during the study period
- Discharged to home from the visit
You may not qualify if:
- Clinicians
- Saw less than 100 patients in the prior year
- Practiced primarily at another site that is not in the main trial
- Did not practice at Sutter Health in the prior 90 days
- Patients
- Currently pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- Donaghue Medical Research Foundationcollaborator
- Sutter Healthcollaborator
Study Sites (1)
Sutter Heath
Walnut Creek, California, 94596, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mitesh Patel, MD, MBA, MS
University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Amol Navathe, MD, PhD
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2019
First Posted
January 31, 2019
Study Start
September 3, 2019
Primary Completion
March 2, 2020
Study Completion
March 2, 2020
Last Updated
March 6, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share